Perspective Therapeutics ( NYSE: CATX ) said it has priced an underwritten offering of 51.5M shares at an offering price of $1.51 per share and, to certain investors in lieu of common stock, pre-funded warrants to purchase 1.
5M shares of its common stock at $1.509 apiece. The offering is expected to raise $80M of gross proceeds.
More on Perspective Therapeutics Perspective Therapeutics partners with Bristol Myers for its metastatic melanoma treatment study.
